Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion type Assertion NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_head.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion description "[Patients with the IFN type I signature showed: (a) higher EULAR Sj�gren's Syndrome Disease Activity Index scores; higher anti-Ro52, anti-Ro60 and anti-La autoantibodies; higher rheumatoid factor; higher serum IgG; lower C3, lower absolute lymphocyte and neutrophil counts; (b)higher BAFF gene expression in monocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_provenance.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion evidence source_evidence_literature NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_provenance.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion SIO_000772 22736090 NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_provenance.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion wasDerivedFrom befree-20140225 NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_provenance.
- NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_assertion wasGeneratedBy ECO_0000203 NP615389.RAHo58s4IKnnvXOQ3BVVMmwkp1tk1REG6sn2E7cgxRUvQ130_provenance.